Share
As the COVID-19 pandemic continues to roil the world’s healthcare systems, endocrinologists may have unique insights that could save lives and improve outcomes in these patients who present with elevated glucose levels and other underlying comorbidities such as obesity and diabetes. When this issue went to press, the U.S. had the most cases of COVID-19...
Share
Study reports the first known case of subacute thyroiditis after COVID-19 infection COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism. Subacute thyroiditis is an inflammatory thyroid disease characterized by neck pain and is usually preceded by an upper respiratory tract infection. It may be caused by a viral infection or a post-viral inflammatory reaction, and many...
Share
Consuming sucralose-sweetened beverages with carbohydrates may impair insulin sensitivity, according to a study recently published in Cell Metabolism. Researchers led by Dana M. Small, PhD, director of the Modern Diet and Physiology Research Center at Yale University in New Haven, Conn., point out that there is still significant controversy surrounding the effects of no- or...
Share
Endocrine-related disorders can put many patients at risk for severe COVID-19 complications. An editorial in The Journal of Clinical Endocrinology & Metabolism provides recommendations for the specialists who treat these patients to ensure optimal care. The special needs of COVID-19 patients with endocrine-related disorders must be championed lest they be overlooked in the crush...
Share
When the Endocrine Society launches ENDO Online 2020 in June, attendees will be treated to Mirjam Christ-Crain, MD, PhD, from the University of Basel, Switzerland, who will discuss the top pituitary research studies in her session, “The Year in Pituitary: Clinical and Research Breakthroughs.” For such a miniscule structure, the pea-sized hypophysis plays an outsized...
Share
The Endocrine Society joined a coalition of leading bone health organizations to release guidance for healthcare professionals treating patients with osteoporosis in the era of COVID-19. The guidelines address the challenges that social distancing has presented for treating patients with osteoporosis, including those who receive treatment through injection or intravenous (IV) delivery of drugs. It also provides guidance on how some patients may be transitioned to alternative therapies until they are able...
Share
With the severe disruption to research activity due to the COVID-19 pandemic causing strain at labs across the country, the National Institutes of Health (NIH) has had to quickly address the situation for the workforce while also mobilizing to support research activities related to the virus and comorbidities. Despite the extreme challenge of the situation,...
Share
Endocrine News spoke with J. Larry Jameson, MD, PhD, editor-in-chief, Journal of the Endocrine Society, about his March editorial in the New York Times that urged physical distancing in order to save lives. He discusses the editorial’s impact, the importance of videoconferencing, and COVID-19’s lasting impact on healthcare. On March 24, J. Larry Jameson, MD,...
